Altasciences, one of the largest early phase clinical CROs in North America, is pleased to announce that Chris Perkin, CEO, has been named one of the 100 Most Inspiring People in the Life-Sciences Industry by PharmaVOICE magazine for the second time.
Altasciences Clinical Research announced today that its clinical facility, Algorithme Pharma, in Montreal, Canada, has received its iCardiac Certification.
Altasciences Clinical Research announced today that its companies, Algorithme Pharma and Vince & Associates Clinical Research, have been identified as industry leaders by biopharmaceutical companies worldwide.
Altasciences Clinical Research’s companies Algorithme Pharma, Vince & Associates Clinical Research and Algorithme Pharma USA announced today that they are adopting a new look, including new logos.
Algorithme Pharma Announces the Appointment of an Executive Vice President, Phase I Clinical Development
Algorithme Pharma of the Altasciences Group, a full service provider focused on early stage clinical research, today announced the addition of Dr. Graham Wood, Executive Vice President, Phase I Clinical Development to the team.